188 related articles for article (PubMed ID: 29892181)
21. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
[TBL] [Abstract][Full Text] [Related]
22. A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values.
Jin GZ; Dong H; Yu WL; Li Y; Lu XY; Yu H; Xian ZH; Dong W; Liu YK; Cong WM; Wu MC
BMC Cancer; 2013 Mar; 13():161. PubMed ID: 23537217
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
[TBL] [Abstract][Full Text] [Related]
24. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.
Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F
Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453
[TBL] [Abstract][Full Text] [Related]
26. [Dysplastic nodule of liver versus early hepatocellular carcinoma: a clinicopathologic and prognostic study].
Chen L; Tan Y; Zeng H; Hou Y; Xu J; Zhao J; Ji Y
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):301-6. PubMed ID: 25030861
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma.
Shin E; Ryu HS; Kim SH; Jung H; Jang JJ; Lee K
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):544-50. PubMed ID: 21234611
[TBL] [Abstract][Full Text] [Related]
28. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
29. Multiple occurrence of borderline hepatocellular nodules in human cirrhotic livers: possible multicentric origin of hepatocellular carcinoma.
Terada T; Nakanuma Y
Virchows Arch; 1995; 427(4):379-83. PubMed ID: 8548122
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.
Shafizadeh N; Kakar S
Adv Anat Pathol; 2011 Nov; 18(6):438-45. PubMed ID: 21993269
[TBL] [Abstract][Full Text] [Related]
31. Stromal morphological changes and immunophenotypic features of precancerous lesions and hepatocellular carcinoma.
Chen D; Li Z; Zhu W; Cheng Q; Song Q; Qian L; Zhu JY
J Clin Pathol; 2019 Apr; 72(4):295-303. PubMed ID: 30610005
[TBL] [Abstract][Full Text] [Related]
32. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
Wang XY; Degos F; Dubois S; Tessiore S; Allegretta M; Guttmann RD; Jothy S; Belghiti J; Bedossa P; Paradis V
Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
[TBL] [Abstract][Full Text] [Related]
33. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions.
Ojima H; Masugi Y; Tsujikawa H; Emoto K; Fujii-Nishimura Y; Hatano M; Kawaida M; Itano O; Kitagawa Y; Sakamoto M
Cancer Sci; 2016 Apr; 107(4):543-50. PubMed ID: 26797961
[TBL] [Abstract][Full Text] [Related]
34. Vascular immunohistochemical markers: contributions to hepatocellular nodule diagnosis in explanted livers.
Nascimento C; Caroli-Bottino A; Paschoal J; Pannain VL
Transplant Proc; 2009 Dec; 41(10):4211-3. PubMed ID: 20005371
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.
Caroli-Bottino A; Nascimento CM; Basto S; Ribeiro J; Silveira V; Carvalho AM; Castro PN; Villela-Nogueiro CA; Pannain VL
Transplant Proc; 2005; 37(6):2791-2. PubMed ID: 16182811
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular dysplastic nodules.
Roncalli M; Borzio M; Di Tommaso L
Ann Ital Chir; 2008; 79(2):81-9. PubMed ID: 18727269
[TBL] [Abstract][Full Text] [Related]
37. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M
Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043
[TBL] [Abstract][Full Text] [Related]
38. HCRP1, ID4 and Glypican-3: an optimal panel of biomarkers for diagnosis of hepatocellular carcinoma.
Ge S; Wang D; Lv B; Yang S; Liu C; Xu B; Zhao C; Qin Y; Xu J
Int J Clin Exp Pathol; 2018; 11(12):5774-5782. PubMed ID: 31949663
[TBL] [Abstract][Full Text] [Related]
39. The cytological characteristics of small cell change of dysplasia in small hepatic nodules.
Chang O; Yano Y; Masuzawa A; Fukushima N; Teramura K; Hayashi Y
Oncol Rep; 2010 May; 23(5):1229-32. PubMed ID: 20372834
[TBL] [Abstract][Full Text] [Related]
40. MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers.
Macarini L; Milillo P; Cascavilla A; Scalzo G; Stoppino L; Vinci R; Moretti G; Ettorre G
Radiol Med; 2009 Dec; 114(8):1267-82. PubMed ID: 19902328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
